Health News Releases

09:33

GE HealthCare to Acquire SOFIE Biosciences, Establishing a ‘Final Mile’ Footprint for PET Radiopharmaceutical Supply in the U.S.

GE HealthCare (Nasdaq: GEHC) today announced a definitive agreement to acquire SOFIE Biosciences, a leading U.S.-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase pr

October 05, 15:35

Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026

Agenus Inc. (https://www.agenusbio.com/) (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced three-year follow-up results from the ovarian cancer cohort of its 400+ patient Phase 1

October 05, 14:50

LISTERINE® Launches Oral Care Counts This World Smile Day as Oral Disease Cases Rise to 3.73 Billion

Nearly half the world’s population is affected by oral disease - and the number of cases is rising. This World Smile Day, LISTERINE® is launching Oral Care Counts - a multiyear education and advocacy

October 05, 12:10

Global Health Leaders to Convene at Abu Dhabi Future Health Summit 2026

Global leaders across healthcare, science, technology, policy, and investment will convene at the Abu Dhabi Future Health Summit from 20 to 22 October 2026 to examine how health systems can better ant

October 05, 11:30

Roquette to Showcase End-to-End Pharma Solutions for Patient-Centric Formulations at CPHI Milan 2026

Roquette will showcase its end-to-end portfolio of pharmaceutical excipients, drug delivery solutions and leading technical expertise at CPHI Milan 2026 in Italy, where the company will welcome visito

October 02, 11:50

Neutrogena®, Aveeno®, and Regaine® Present New Scientific Evidence Demonstrating How Science-Backed Ingredients Support Healthy Skin and Hair

Neutrogena®, Aveeno®, and Regaine®* will present 12 new scientific data sets at the 35th European Academy of Dermatology and Venereology (EADV) Congress taking place September 30th through October 3rd

October 02, 09:54

Samsung Bioepis and Teva Expand Strategic Partnership to Advance Up to Six Potential Biosimilar Candidates

Samsung Bioepis Co., Ltd. and Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the companies have entered into a global license, development, and commercialization agreem

October 01, 16:50

HairON Develops ‘FolliOn Injection’ Focused on Restoring Hair Follicle Function

HairON (https://haironclinic.com/en/), a brand specializing in scalp and hair loss care, has unveiled the brand story behind its newly developed ‘FolliOn Injection,’ which focuses on restoring hair fo

October 01, 16:00

Promega Launches Paradyme™ 27GY STR System, Minimizing Stutter Artifacts in Forensic DNA Analysis

Promega Corporation has launched Paradyme™ 27GY STR System, the first commercially available short tandem repeat (STR) analysis kit to include the company’s Reduced-Stutter Polymerase (RSP). This nove

October 01, 15:47

HairON Clinic Completes Trademark Registration for ‘FolliOn,’ a Hair Loss Treatment Combining PDRN, Growth Factors and Spicules

HairON Clinic (https://haironclinic.com/en/), which specializes in hair loss treatment, announced that it has completed the trademark registration for ‘FolliOn,’ a next-generation hair loss treatment

September 30, 17:31

EADV 2026: Galderma’s New Data Show Sustained Improvements with Nemluvio® (nemolizumab) for up to Three Years in Patients With Moderate-to-severe Atopic Dermatitis

Galderma (SIX: GALD), the pure-play dermatology category leader, is presenting new three-year data from the ARCADIA long-term extension study, demonstrating that Nemluvio is well-tolerated and associa

September 30, 10:30

KARA Clinical Ambassador Network Tops 800 Members in Korea and Expands to Latin America

KARA Clinical Global (https://karaclinical.com/en), the Seoul-based at-home skincare technology company, today announced that the KARA Clinical Ambassador Network (KCAN) has grown to more than 800 amb

September 27, 15:40

Future Health Convenes Global Health Leaders at UNGA to Advance Health System Transformation at Scale

Future Health - A Global Initiative by Abu Dhabi convened Ministers, senior government representatives, and global health leaders in New York on the sidelines of the 81st Session of the United Nations

September 26, 15:55

Novotech to acquire Agilex Biolabs

Novotech, the global full-service clinical research organisation (CRO) and scientific advisory company, today announced it has reached agreement with a wholly owned subsidiary of leading Australian he

September 26, 14:30

The Estée Lauder Companies and the Breast Cancer Research Foundation Launch Largest Global Research Initiative on Breast Cancer in Younger Women

The Estée Lauder Companies today announced a new five-year commitment to the Breast Cancer Research Foundation to establish the Global Research Initiative on Breast Cancer in Younger Women. This first

September 26, 11:45

Future Health - A Global Initiative by Abu Dhabi: New Analysis Estimates Modifiable Health Risks Represent $16.4 Trillion Annual Global GDP Opportunity in 2050

Addressing behavioural, metabolic and environmental health risks could generate an estimated $16.4 trillion in annual global GDP uplift in 2050. These findings are presented in The Future of Healthy L

September 26, 10:57

Acadia Pharmaceuticals Announces Phase 3 Enabling Topline Results from Phase 2 RADIANT Study of Remlifanserin for the Treatment of Alzheimer’s Disease Psychosis (ADP)

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced Phase 3 enabling topline results from the Phase 2 portion of the ongoing RADIANT clinical trial program evaluating remlifanserin for the trea

September 26, 09:55

Copeland Completes Acquisition of Dickson, Advancing Cold Chain Intelligence for Healthcare and Life Sciences

Copeland, a global leader in compression technologies and controls solutions, today announced it has completed the acquisition of Dickson, a Chicago-based provider of environmental monitoring and comp

September 23, 17:13

Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 2026

Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Foverview%2F&esheet=54608238&newsitemid=20260921356638&lan=en-US&anchor=TSE%3A4

September 23, 17:00

From CSR to Public Health Impact: How Colgate Bright Smiles, Bright Futures® is Driving Behavior Change for the Next Billion Children and Their Families

Colgate-Palmolive, the worldwide leader in oral care, announced a strategic evolution in its flagship oral health education program, Colgate Bright Smiles, Bright Futures® (BSBF), reflecting the Compa

September 23, 16:45

EADV 2026: Galderma to Unveil New Data Advancing Understanding of Skin Diseases, Skin Longevity, and Real-world Patient Experiences

Galderma (SIX: GALD), the pure-play dermatology category leader, will present 19 abstracts and deliver a broad scientific education program at the 2026 European Academy of Dermatology and Venereology

September 23, 10:56

Onnuri Smile Eye Clinic’s 1mm SMILE Pro Technique Draws Attention for Surgical Safety and Recovery

Onnuri Smile Eye Clinic (https://www.onnurismile.com/), an ophthalmology clinic in South Korea, announced that its proprietary, patented 1mm ultra-small-incision SMILE Pro technique is drawing great a

September 21, 15:19

Galderma Begins Trading in the Swiss Market Index, Joining Switzerland's Leading Blue Chip Companies

Galderma (SIX: GALD), the pure-play dermatology category leader, today begins trading as a constituent of the Swiss Market Index (SMI), Switzerland‘s leading blue chip equity benchmark comprising 20 o

September 18, 17:47

Takeda Employees Select Four New Global Corporate Social Responsibility Collaborations to Advance Climate-Resilient Health Systems

Takeda (TSE:4502/NYSE: TAK) announced that it has awarded a total of USD 22.2 million to four new Global Corporate Social Responsibility (CSR) partners as part of the company’s ongoing commitment to s

September 18, 16:00

Medisca Launches Global Peptide Division

Medisca today announced the launch of Medisca Peptides, a dedicated global division focused on expanding access to API-grade peptides and building an integrated peptide platform for pharmaceutical and

News by Region

News by Industry